Skip to main content

Table 3 Demographic and baseline characteristics (ITT population)

From: Dexketoprofen/tramadol 25 mg/75 mg: randomised double-blind trial in moderate-to-severe acute pain after abdominal hysterectomy

 

DKP/TRAM

DKP

TRAM

Overall

SDP placebo (N = 51)

SDP active (N = 152)

All (N = 203)

SDP placebo (N = 51)

SDP active (N = 151)

All (N = 202)

SDP placebo (N = 51)

SDP active (N = 150)

All (N = 201)

Overall (N = 606)

Race N (%)

White

51 (100 %)

152 (100 %)

203 (100 %)

51 (100 %)

151 (100 %)

202 (100 %)

51 (100 %)

150 (100 %)

201 (100 %)

606 (100 %)

Age (years)

mean

47

48

48

47

47

47

47

48

48

48

SD

6.8

6.7

6.7

7.5

7.1

7.2

4.6

6.9

6.4

6.8

min

35

25

25

30

31

30

39

32

32

25

max

69

73

73

71

70

71

61

68

68

73

Height (cm)

mean

165

164

164

164

164

164

164

164

164

164

SD

6.2

5.4

5.6

5.9

6.4

6.3

5.6

6.1

6.0

5.9

min

149

152

149

136

151

136

153

149

149

136

max

175

176

176

175

183

183

176

182

182

183

Weight (kg)

mean

74

75

75

73

72

72

73

71

72

73

SD

14

15

15

15

14

14

11

12

12

14

min

52

48

48

50

45

45

50

49

49

45

max

114

120

120

112

110

112

90

106

106

120

Country

Hungary

8 (16 %)

22 (15 %)

30 (15 %)

7 (14 %)

19 (13 %)

26 (13 %)

7 (14 %)

26 (17 %)

33 (16 %)

89 (15 %)

Latvia

7 (14 %)

22 (15 %)

29 (14 %)

4 (7.8 %)

17 (11 %)

21 (10 %)

5 (9.8 %)

17 (11 %)

22 (11 %)

72 (12 %)

Lithuania

1 (2.0 %)

2 (1.3 %)

3 (1.5 %)

1 (2.0 %)

4 (2.6 %)

5 (2.5 %)

3 (5.9 %)

3 (2.0 %)

6 (3.0 %)

14 (2.3 %)

Poland

18 (35 %)

63 (41 %)

81 (40 %)

23 (45 %)

53 (35 %)

76 (38 %)

17 (33 %)

60 (40 %)

77 (38 %)

234 (39 %)

Romania

10 (20 %)

32 (21 %)

42 (21 %)

12 (24 %)

40 (27 %)

52 (26 %)

12 (24 %)

32 (21 %)

44 (22 %)

138 (23 %)

Russian Federation

2 (3.9 %)

3 (2.0 %)

5 (2.5 %)

2 (3.9 %)

3 (2.0 %)

5 (2.5 %)

2 (3.9 %)

3 (2.0 %)

5 (2.5 %)

15 (2.5 %)

Slovakia

5 (9.8 %)

7 (4.6 %)

12 (5.9 %)

2 (3.9 %)

13 (8.6 %)

15 (7.4 %)

4 (7.8 %)

8 (5.3 %)

12 (6.0 %)

39 (6.4 %)

Spain

0 (0 %)

1 (0.7 %)

1 (0.5 %)

0 (0 %)

2 (1.3 %)

2 (1.0 %)

1 (2.0 %)

1 (0.7 %)

2 (1.0 %)

5 (0.8 %)

Baseline PI (VAS) N (%)

moderate

19 (37 %)

59 (39 %)

78 (38 %)

19 (37 %)

58 (38 %)

77 (38 %)

19 (38 %)

57 (38 %)

76 (38 %)

231 (38 %)

severe

32 (63 %)

93 (61 %)

125 (62 %)

32 (63 %)

93 (62 %)

125 (62 %)

31 (62 %)

93 (62 %)

124 (62 %)

374 (62 %)

  1. ITT intention-to-treat, DKP/TRAM dexketoprofen trometamol/tramadol hydrochloride 25 mg/75 mg, DKP dexketoprofen trometamol 25 mg, TRAM tramadol hydrochloride 100 mg, SDP single-dose phase, N number of patients, SD standard deviation, PI pain intensity, VAS visual analogue scale. The ITT population included all randomised patients; PI was measured on a 0–100 VAS with the left end labelled “no pain” and the right end labelled “worst possible pain”
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us